SCM
HALO icon

Silverarc Capital Management’s Halozyme HALO Stock Holding History

Silverarc Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-71,009
Closed -$2.85M – 75
2021
Q4 		$2.85M Buy
71,009
+10,839
+18% +$405K 1.16% 28
2021
Q3 		$2.45M Sell
60,170
-6,503
-10% -$272K 1.38% 23
2021
Q2 		$3.03M Sell
66,673
-38,272
-36% -$1.69M 1.35% 23
2021
Q1 		$4.38M Buy
104,945
+4,945
+5% +$226K 2.39% 12
2020
Q4 		$4.27M Buy
+100,000
New +$3.59M 2.48% 13

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Silverarc Capital Management's HALO Position: Q1 2022 in Review

Silverarc Capital Management sold out of Halozyme (HALO) in Q1 2022, closing a stake of 71,009 shares — an estimated $2.85M sold.

Silverarc Capital Management first reported a position in HALO in Q4 2020 and held it in 5 quarters. The position peaked at $4.38M in Q1 2021. 318 funds tracked by Wall St. Rank hold HALO as of Q1 2022.

  • Silverarc Capital Management reported no remaining Halozyme position as of Q1 2022 after selling out during the quarter.
  • Silverarc Capital Management sold 71,009 Halozyme shares in Q1 2022, an estimated $2.85M.
  • Silverarc Capital Management first reported a position in Halozyme in Q4 2020 and held it in 5 quarters.
  • Silverarc Capital Management's Halozyme position peaked at $4.38M in Q1 2021.
  • 318 funds tracked by Wall St. Rank held Halozyme as of Q1 2022.

Based on Silverarc Capital Management's 13F filing for Q1 2022, filed 13 May 2022.